Resolving mechanisms of immune-mediated disease in primary CD4 T cells.
Saved in:
| Title: | Resolving mechanisms of immune-mediated disease in primary CD4 T cells. |
|---|---|
| Authors: | Bourges C; Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, University of Cambridge, Cambridge, UK.; Department of Medicine, University of Cambridge School of Clinical Medicine, Addenbrooke's Hospital, Cambridge, UK., Groff AF; Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA, USA., Burren OS; Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, University of Cambridge, Cambridge, UK.; Department of Medicine, University of Cambridge School of Clinical Medicine, Addenbrooke's Hospital, Cambridge, UK., Gerhardinger C; Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA, USA., Mattioli K; Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA, USA., Hutchinson A; MRC Biostatistics Unit, Cambridge Institute of Public Health, Cambridge, UK., Hu T; Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, University of Cambridge, Cambridge, UK.; Department of Medicine, University of Cambridge School of Clinical Medicine, Addenbrooke's Hospital, Cambridge, UK., Anand T; Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, University of Cambridge, Cambridge, UK.; Department of Medicine, University of Cambridge School of Clinical Medicine, Addenbrooke's Hospital, Cambridge, UK., Epping MW; Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, University of Cambridge, Cambridge, UK.; Department of Medicine, University of Cambridge School of Clinical Medicine, Addenbrooke's Hospital, Cambridge, UK., Wallace C; Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, University of Cambridge, Cambridge, UK.; Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA, USA., Smith KG; Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, University of Cambridge, Cambridge, UK.; Department of Medicine, University of Cambridge School of Clinical Medicine, Addenbrooke's Hospital, Cambridge, UK., Rinn JL; Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA, USA.; Department of Biochemistry, BioFrontiers Institute, University of Colorado, Boulder, CO, USA., Lee JC; Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, University of Cambridge, Cambridge, UK.; Department of Medicine, University of Cambridge School of Clinical Medicine, Addenbrooke's Hospital, Cambridge, UK.; Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA, USA. |
| Source: | EMBO molecular medicine [EMBO Mol Med] 2020 May 08; Vol. 12 (5), pp. e12112. Date of Electronic Publication: 2020 Apr 01. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: EMBO Press Country of Publication: Germany NLM ID: 101487380 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1757-4684 (Electronic) Linking ISSN: 17574676 NLM ISO Abbreviation: EMBO Mol Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1757-4684 |
|---|---|
| DOI: | 10.15252/emmm.202012112 |
